The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study
Open accessAbstract
Background—: The prevalence of heart failure with preserved ejection fraction is increasing. The prognosis worsens with pulmonary hypertension and right ventricular (RV) failure development. We targeted pulmonary hypertension and RV burden with the phosphodiesterase-5 inhibitor sildenafil. Methods and Results—: Forty-four patients with heart failure with preserved ejection fraction (heart failure signs and symptoms, diastolic dysfunction, ejection fraction ≥50%, and pulmonary artery systolic pressure >40 mm Hg) were randomly assigned to placebo or sildenafil (50 mg thrice per day). At 6 months, there was no improvement with placebo, but sildenafil mediated significant improvements in mean pulmonary artery pressure (−42.0±13.0%) and RV function, as suggested by leftward shift of the RV Frank-Starling relationship, increased tricuspid annular systolic excursion (+69.0±19.0%) and ejection rate (+17.0±8.3%), and reduced right atrial pressure (−54.0±7.2%). These effects may have resulted from changes within the lung (reduced lung water content and improved alveolar-capillary gas conductance, +15.8±4.5%), the pulmonary vasculature (arteriolar resistance, −71.0±8.2%), and left-sided cardiac function (wedge pulmonary pressure, −15.7±3.1%; cardiac index, +6.0±0.9%; deceleration time, −13.0±1.9%; isovolumic relaxation time, −14.0±1.7%; septal mitral annulus velocity, −76.4±9.2%). Results were similar at 12 months. Conclusions—: The multifaceted response to phosphodiesterase-5 inhibition in heart failure with preserved ejection fraction includes improvement in pulmonary pressure and vasomotility, RV function and dimension, left ventricular relaxation and distensibility (structural changes and/or ventricular interdependence), and lung interstitial water metabolism (wedge pulmonary pressure decrease improving hydrostatic balance and right atrial pressure reduction facilitating lung lymphatic drainage). These results enhance our understanding of heart failure with preserved ejection fraction and offer new directions for therapy. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT01156636.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standardization of Spirometry, 1994 Update. American Thoracic Society.
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,594
Spirometric Reference Values from a Sample of the General U.S. Population
HANKINSON, J. L., ODENCRANTZ, J. R., & FEDAN, K. B. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9712108 · Cited by 4,206
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,191
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
Recommendations for chamber quantification☆
LANG, R., BIERIG, M., DEVEREUX, R., FLACHSKAMPF, F., FOSTER, E., PELLIKKA, P., PICARD, M., ROMAN, M., SEWARD, J., & SHANEWISE, J. (2006) · European Journal of Echocardiography · doi:10.1016/j.euje.2005.12.014 · Cited by 3,571
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study
Bhatia, R. S., Tu, J. V., Lee, D. S., Austin, P. C., Fang, J., Haouzi, A., Gong, Y., & Liu, P. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051530 · Cited by 1,967
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042934 · Cited by 1,773
Mullens, W., Abrahams, Z., Francis, G. S., Sokos, G., Taylor, D. O., Starling, R. C., Young, J. B., & Tang, W. H. W. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.068 · Cited by 1,674
Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
Lam, C. S. P., Roger, V. L., Rodeheffer, R. J., Borlaug, B. A., Enders, F. T., & Redfield, M. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.051 · Cited by 1,341
Ghio, S., Gavazzi, A., Campana, C., Inserra, C., Klersy, C., Sebastiani, R., Arbustini, E., Recusani, F., & Tavazzi, L. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01102-5 · Cited by 1,289
Assessment of right ventricular function using two-dimensional echocardiography
Kaul, S., Tei, C., Hopkins, J. M., & Shah, P. M. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90095-4 · Cited by 1,037
Roughton, F. J. W., & Forster, R. E. (1957) · Journal of Applied Physiology · doi:10.1152/jappl.1957.11.2.290 · Cited by 999
Damman, K., van Deursen, V. M., Navis, G., Voors, A. A., van Veldhuisen, D. J., & Hillege, H. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.080 · Cited by 986
Califf, R. M., Adams, K. F., McKenna, W. J., Gheorghiade, M., Uretsky, B. F., McNulty, S. E., Darius, H., Schulman, K., Zannad, F., Handberg-Thurmond, E., et al. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)70105-4 · Cited by 665
Nagendran, J., Archer, S. L., Soliman, D., Gurtu, V., Moudgil, R., Haromy, A., St. Aubin, C., Webster, L., Rebeyka, I. M., Ross, D. B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.655266 · Cited by 530
Lewis, G. D., Shah, R., Shahzad, K., Camuso, J. M., Pappagianopoulos, P. P., Hung, J., Tawakol, A., Gerszten, R. E., Systrom, D. M., Bloch, K. D., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.716373 · Cited by 515
Moraes, D. L., Colucci, W. S., & Givertz, M. M. (2000) · Circulation · doi:10.1161/01.cir.102.14.1718 · Cited by 401
Guazzi, M., Vicenzi, M., Arena, R., & Guazzi, M. D. (2011) · Circulation: Heart Failure · doi:10.1161/circheartfailure.110.944694 · Cited by 382
Self-citationChantler, P. D., Lakatta, E. G., & Najjar, S. S. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90600.2008 · Cited by 360
Development and testing of a new measure of health status for clinical trials in heart failure
Guyatt, G. H., Nogradi, S., Halcrow, S., Singer, J., Sullivan, M. J. J., & Fallen, E. L. (1989) · Journal of General Internal Medicine · doi:10.1007/bf02602348 · Cited by 335
Clinical Effectiveness of Beta-Blockers in Heart Failure
Hernandez, A. F., Hammill, B. G., O'Connor, C. M., Schulman, K. A., Curtis, L. H., & Fonarow, G. C. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.031 · Cited by 333
Solomon, S. D., Janardhanan, R., Verma, A., Bourgoun, M., Daley, W. L., Purkayastha, D., Lacourcière, Y., Hippler, S. E., Fields, H., Naqvi, T. Z., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60980-5 · Cited by 329
Long-Term Use of Sildenafil in the Therapeutic Management of Heart Failure
Guazzi, M., Samaja, M., Arena, R., Vicenzi, M., & Guazzi, M. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.078 · Cited by 323
Self-citationOh, J. K., Hatle, L., Tajik, A. J., & Little, W. C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.032 · Cited by 318
Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Chronic Heart Failure
Delgado, J. F., Conde, E., Sánchez, V., López-Ríos, F., Gómez-Sánchez, M. A., Escribano, P., Sotelo, T., de la Cámara, A. G., Cortina, J., & de la Calzada, C. S. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.10.021 · Cited by 289
Heart Failure With Normal Left Ventricular Ejection Fraction
Maeder, M. T., & Kaye, D. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.007 · Cited by 270
Rivas-Gotz, C., Khoury, D. S., Manolios, M., Rao, L., Kopelen, H. A., & Nagueh, S. F. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)01034-9 · Cited by 179
Pulmonary hemodynamics and right ventricular function in hypertension.
OLIVARI, M. T., Fiorentini, C., Polese, A., & Guazzi, M. D. (1978) · Circulation · doi:10.1161/01.cir.57.6.1185 · Cited by 105
Self-citationCurrent Perspectives on Cardiac Function in Patients With Diastolic Heart Failure
Wang, J., & Nagueh, S. F. (2009) · Circulation · doi:10.1161/circulationaha.108.822676 · Cited by 91
Clinical Use of Phosphodiesterase-5 Inhibitors in Chronic Heart Failure
Guazzi, M. (2008) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.802116 · Cited by 64
Self-citationGuazzi, M., Polese, A., Bartorelli, A., et al. (1982) · Circulation · doi:10.1161/01.cir.66.4.881 · Cited by 35
Self-citationGuazzi, M., Agostoni, P., & Guazzi, M. D. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01131-1 · Cited by 35
Self-citationEnhanced hypoxic pulmonary vasoconstriction in hypertension.
Guazzi, M., Alimento, M., Berti, M., Fiorentini, C., Galli, C. L., & Tamborini, G. (1989) · Circulation · doi:10.1161/01.cir.79.2.337 · Cited by 24
Self-citationPulmonary vascular supersensitivity to catecholamines in systemic high blood pressure
Guazzi, M. D., Cesare, N. D., Fiorentini, C., Galli, C. A., Montorsi, P., Pepi, M., & Tamborini, G. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80393-x · Cited by 18
Self-citation
Cited by
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00879-2022 · Cited by 2,247
Epidemiology of heart failure with preserved ejection fraction
Dunlay, S. M., Roger, V. L., & Redfield, M. M. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.65 · Cited by 1,534
Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap
Shah, S. J., Kitzman, D. W., Borlaug, B. A., van Heerebeek, L., Zile, M. R., Kass, D. A., & Paulus, W. J. (2016) · Circulation · doi:10.1161/circulationaha.116.021884 · Cited by 1,003
Metadata
- Authors
- Guazzi, M., Vicenzi, M., Arena, R., & Guazzi, M. D.
- Venue
- Circulation
- Published
- 2011-07-12
- Volume
- 124
- Issue
- 2
- Pages
- 164-174
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2082890993
- Cited by
- 545
- References
- 35
- FWCI
- 37.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.